Antsaklis A, Politis J, Diacomanolis E, Aravantinos D, Kaskarelis D
Int Surg. 1984 Jan-Mar;69(1):63-8.
The administration of 15-me-PGF 2a for the therapeutic termination of pregnancy and management of intrauterine death of the embryo during the second and third trimester of pregnancy was studied in 92 patients. Of these, 52 came because of intrauterine death with an average gestational age of 28.7 weeks while the rest came for therapeutic termination of pregnancy with an average gestational age of 21 weeks. Successful abortion was achieved in 90 patients. The mean abortion induction time was 7.3 hours for patients with intrauterine death and 12.6 hours for the patients who came for therapeutic termination. The results and complications of the intramuscular administration of the 15-me-PFG2a are analysed in the present work.
对92例妊娠中期和晚期的患者进行了研究，以探讨使用15-甲基前列腺素F2α进行治疗性终止妊娠及处理胚胎宫内死亡的情况。其中，52例因胚胎宫内死亡前来就诊，平均孕周为28.7周，其余患者因治疗性终止妊娠前来就诊，平均孕周为21周。90例患者成功流产。胚胎宫内死亡患者的平均引产时间为7.3小时，因治疗性终止妊娠前来就诊的患者平均引产时间为12.6小时。本文分析了肌肉注射15-甲基前列腺素F2α的结果及并发症。
